[SYRE] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
28-Sep-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -197.32%
YoY- -12.61%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 625 1,362 3,644 1,399 13,696 0 0 -
PBT -22,314 -24,436 -20,423 -20,281 -6,738 -18,218 -22,714 -1.18%
Tax 9 0 23 26 92 0 0 -
NP -22,323 -24,436 -20,446 -20,307 -6,830 -18,218 -22,714 -1.15%
Tax Rate - - - - - - - -
Total Cost 22,948 25,798 24,090 21,706 20,526 18,218 22,714 0.68%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -3,571.68 -1,794.13 -561.09 -1,451.54 -49.87 0.00 0.00 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -6.79 -9.26 -10.36 -7.72 -2.60 -6.94 0.00 -
EPS Diluted -6.79 -9.26 -10.36 -7.72 -2.60 -6.94 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.